I would be, too, Yooo. But Temesgen led Mayo's case controlled study, as well as our LIVE-AIR study. He was one of the authors of our CRP biomarker study. They used lenz as standard of care in some of the Mayo Clinics for which there was IND authorization for the patient. He has been a huge proponent for lenz, despite his affiliation with Gilead.
News 
Market Data 
Discover 
AI
